This product is sold for research purposes only. It is not intended for human consumption, nor is it intended to diagnose, treat, cure, or prevent any disease.
Reconstitute with bacteriostatic (BAC) water for laboratory research preparation.
Overview
PT‑141, also referenced as Bremelanotide, is a synthetic melanocortin receptor
agonist analog supplied in lyophilised form for laboratory research use only.
Preclinical literature examines its binding profile at melanocortin receptor subtypes
(MC3R/MC4R) and associated cAMP‑linked signalling cascades in defined model systems.
Research Context
– Investigated in in vitro assay configurations assessing melanocortin receptor
binding affinity and downstream second‑messenger pathway markers.
– Examined in controlled models referencing GPCR activation profiles and
signal‑transduction readouts.
– Findings are model‑specific and limited to defined experimental conditions.
Format and Documentation
– Lyophilised peptide; nominal content: 5 mg per vial
– Certificate of Analysis (COA) provided for each lot
– Storage guidance for research environments on label/COA
Compliance
For laboratory research use only (RUO). Not for human or veterinary use, diagnostic
or therapeutic applications.
FAQ
What is PT‑141 in research contexts?
A melanocortin receptor agonist analog examined in controlled in vitro models for
receptor binding and GPCR signalling marker readouts.
Do you provide a COA?
Yes — each lot is supplied with a Certificate of Analysis.
How should it be stored in a lab?
Follow the label/COA storage guidance suitable for research environments.
Form: Lyophilised powder
Intended use: Laboratory research use only
Documentation: Certificate of Analysis where applicable
Dispatch: Fast UK fulfilment
Storage:
– Powder: -20°C 3 years ; 4°C 2 years ; 15°C 3 month
– In solvent: -80°C 6 months ; -2°C 1 month ; 10°C 1 week
Product disclaimer
This product is supplied strictly for laboratory research use only. Not for human or veterinary
Reviews
There are no reviews yet.